Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00711724
NCT00711724
Completed
Not Applicable

Comparison of Self and Clinician Administered Rating Scales in Patients With Attention Deficit Hyperactivity Disorder (ADHD)

Massachusetts General Hospital1 site in 1 country50 target enrollmentJuly 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAttention-Deficit/Hyperactivity Disorder (ADHD)

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Attention-Deficit/Hyperactivity Disorder (ADHD)
Sponsor
Massachusetts General Hospital
Enrollment
50
Locations
1
Primary Endpoint
The ADHD-RS and ASRS v1.1 Symptom Checklist scales
Status
Completed
Last Updated
15 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The primary objective is to establish the concurrent validity of the clinician administered Attention Deficit Hyperactivity Disorder-Rating Scale (ADHD-RS) and the patient administered Attention Deficit Hyperactivity Disorder Self Report Scale (ASRS) v1.1 Symptom Checklist.

Registry
clinicaltrials.gov
Start Date
July 2007
End Date
March 2009
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Diagnosis of ADHD
  • •Age 13-65\* \*Parental consent and patient's assent will be obtained for minors participating in this protocol (only adolescents aged 13-18 yrs old will be included in the MGH site)

Exclusion Criteria

  • •Inability to reliably report ADHD symptoms at the discretion of the investigator

Outcomes

Primary Outcomes

The ADHD-RS and ASRS v1.1 Symptom Checklist scales

Time Frame: Weeks 1, 2, 3, 4, 5, 6, 7, or 8

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Patient Performed Examination for Patients With Intra-articular Hip PainHip DiseaseHip Pain Chronic
NCT03248934Duke University80
Completed
Not Applicable
The Clinical and Subjective Performance of Three Different MPDS With Silicon Hydrogel LensesAdverse Reaction to Contact Lens Solution
NCT01665612Finnsusp Ltd.40
Completed
Phase 3
Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax MalariaMalaria
NCT01378286Sanofi380
Completed
Phase 3
Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant Human Chorionic Gonadotrophin in Women Undergoing In Vitro FertilisationInfertility
NCT00335569IBSA Institut Biochimique SA144
Completed
Phase 1
Pharmacokinetic Equivalence and Safety Study of RPH-001 and Avastin®Healthy
NCT03659305R-Pharm80